1. Cartilage-targeting peptide-modified dual-drug delivery nanoplatform with NIR laser response for osteoarthritis therapy
- Author
-
Song Xue, Haiming Lu, Xiaojun Zhou, Cong Wang, Libo Zhu, Jinzhong Ma, Yiming Zhong, Chuanglong He, Weilin Sang, and Yiming Xu
- Subjects
QH301-705.5 ,0206 medical engineering ,Biomedical Engineering ,02 engineering and technology ,Chondrocyte ,Article ,Biomaterials ,In vivo ,Osteoarthritis ,medicine ,Autophagy ,Biology (General) ,Materials of engineering and construction. Mechanics of materials ,Targeting therapy ,chemistry.chemical_classification ,Reactive oxygen species ,Cartilage ,AMPK ,Energy metabolism ,021001 nanoscience & nanotechnology ,020601 biomedical engineering ,Cell biology ,medicine.anatomical_structure ,chemistry ,Oxidative stress ,Drug delivery ,TA401-492 ,Nanocarriers ,0210 nano-technology ,Biotechnology - Abstract
Cartilage-targeting delivery of therapeutic agents is still an effective strategy for osteoarthritis (OA) therapy. Recently, scavenging for reactive oxygen species (ROS) and activating autophagy have been increasingly reported to treat OA effectively. In this study, we designed, for the first time, a dual-drug delivery system based on metal organic framework (MOF)-decorated mesoporous polydopamine (MPDA) which composed of rapamycin (Rap) loaded into the mesopores and bilirubin (Br) loaded onto the shell of MOF. The collagen II-targeting peptide (WYRGRL) was then conjugated on the surface of above nanocarrier to develop a cartilage-targeting dual-drug delivery nanoplatform (RB@MPMW). Our results indicated the sequential release of two agents from RB@MPMW could be achieved via near-infrared (NIR) laser irritation. Briefly, the rapid release of Br from the MOF shell exhibited excellent ROS scavenging ability and anti-apoptosis effects, however responsively reduced autophagy activity, to a certain extent. Meanwhile, following the NIR irradiation, Rap was rapidly released from MPDA core and further enhanced autophagy activation and chondrocyte protection. RB@MPMW continuously phosphorylated AMPK and further rescued mitochondrial energy metabolism of chondrocytes following IL-1β stimulation via activating SIRT1-PGC-1α signaling pathway. Additionally, the cartilage-targeting property of peptide-modified nanocarrier could be monitored via Magnetic Resonance (MR) and IVIS imaging. More significantly, RB@MPMW effectively delayed cartilage degeneration in ACLT rat model. Overall, our findings indicated that the as-prepared dual-drug delivery nanoplatform exerted potent anti-inflammation and anti-apoptotic effects, rescued energy metabolism of chondrocytes in vitro and prevented cartilage degeneration in vivo, which thereby showed positive performance for OA therapy., Graphical abstract The mechanism of dual-drug delivery nanoplatform with cartilage-targeting effect and NIR laser response for OA therapy.Image 1, Highlights • Collagen type II-targeting peptide and positive surface potential endow RB@MPMW with a fine cartilage affinity ability. • RB@MPMW possess superb biological functions of scavenging free radicals and autophagy induction. • RB@MPMW effectively promotes chondrocyte mitochondrial energy metabolism in the inflammatory microenvironment. • RB@MPMW has a good MR imaging ability, which could monitor its therapeutic effects in vivo.
- Published
- 2021